Anxiety disorders in general medical practice – clinical picture, diagnosis, optimized approaches to therapy

• DOI: 10.21518/ms2023-053
• Publication Date: 2023-04-18T13:26:28Z
• Authors: D. S. Petelin; O. Yu. Sorokina; D. V. Troshina; Yu. A. Siginevich; S. M. Efimochkina; B. A. Volel
• Keywords: Anti-Anxiety Agents

Anxiety disorders are widespread in the population and general medical practice have a pronounced negative impact on quality of life functioning patients. Currently, prerequisites for diagnosis treatment anxiety outside psychiatric network accumulating by therapists, practitioners other non-psychiatric doctors. A review most significant factors contributing to wider is given. This presents modern ideas about pathogenesis disorders, substantiates idea their multifactorial nature, contribution genetic epigenetic, psychological social factors, outlines concepts neurobiological basis pathological based neuroimaging studies. In future, information provided manifestations main clusters anxiety, systematics according ICD-10. Modern using both scales clinical approach given, detailed currently available diagnostic validated presented. The approaches conducting conversation also presented, recommendations given successful collection condition At end review, existing psychopharmacotherapy psychotherapy disorders. Taking into account pharmacological studies, place drugs tofisopam (an atypical allosteric modulator GABA receptors) buspirone (a partial agonist serotonin 1A has been argued.